Last reviewed · How we verify
Angelica Sinensis
Angelica sinensis (Chinese angelica root) contains bioactive compounds that promote blood circulation, reduce inflammation, and modulate immune function.
Angelica sinensis (Chinese angelica root) contains bioactive compounds that promote blood circulation, reduce inflammation, and modulate immune function. Used for Blood stasis and circulatory disorders (traditional use), Menstrual irregularities and gynecological conditions (traditional use), Anemia and fatigue (traditional use).
At a glance
| Generic name | Angelica Sinensis |
|---|---|
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
| Modality | Small molecule |
| Therapeutic area | Herbal/Traditional Medicine |
| Phase | FDA-approved |
Mechanism of action
The herb contains coumarins, polysaccharides, and volatile oils that enhance microcirculation, inhibit platelet aggregation, and possess anti-inflammatory properties. It is traditionally used in Chinese medicine to address blood stasis and deficiency conditions, and modern research suggests it may have immunomodulatory and antioxidant effects through multiple pathways.
Approved indications
- Blood stasis and circulatory disorders (traditional use)
- Menstrual irregularities and gynecological conditions (traditional use)
- Anemia and fatigue (traditional use)
Common side effects
- Photosensitivity
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
- A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease (PHASE1, PHASE2)
- Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine. (PHASE2)
- The Treatment of Sepsis Induced Myocardial Dysfunction With Yiqilishui Formula (PHASE2)
- Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia (NA)
- MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits (PHASE2)
- Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD (PHASE2, PHASE3)
- A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome (NA)
- Bufei Recipe Reduces the Incidence Rate of COPD (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: